The levels reached are dependent on several stimulatory pathways controlled by PTH, vitamin D, Ca2+ and P. With fixed PTH levels, if both Ca2+ and vitamin D levels are increased, the increase in FGF23 is higher, probably as a defense mechanism to avoid hyperphosphatemia by decreasing both P levels and vitamin D synthesis. The gene discussed is FGF23; the disease is hyperphosphatemia.